Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) (http://www.rgrdlaw.com/cases/keryx/) today announced that a class action has been commenced on behalf of purchasers of Keryx Biopharmaceuticals, Inc. (“Keryx” or the “Company”) (KERX) common stock during the period between March 2, 2016 and July 29, 2016, inclusive (the “Class Period”). This action was …